Rezultati - Thomas A. DiPetrillo
- Showing 1 - 15 results of 15
-
1
-
2
-
3
-
4
-
5
-
6
RTOG 0913: A Phase 1 Study of Daily Everolimus (RAD001) in Combination With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma od Prakash Chinnaiyan, Minhee Won, Patrick Y. Wen, Amyn M. Rojiani, Merideth M Wendland, Thomas A. DiPetrillo, Benjamin W. Corn, Minesh P. Mehta
Izdano 2013Artigo -
7
-
8
Chemoradiotherapy and Gefitinib in Stage III Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor and KRAS Mutation Analysis: Cancer and Leukemia Group B (CALEB) 30106,... od Neal Ready, Pasi A. Jänne, Jeffrey A. Bogart, Thomas A. DiPetrillo, Jennifer Garst, Stephen L. Graziano, Lin Gu, Xiaofei Wang, Mark R. Green, Everett E. Vokes
Izdano 2010Artigo -
9
-
10
A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective Study (ACOSOG Z4032) od Michael S. Kent, Sumithra J. Mandrekar, Rodney J. Landreneau, Francis Nichols, Nathan R. Foster, Thomas A. DiPetrillo, Bryan F. Meyers, Dwight E. Heron, David R. Jones, Angelina D. Tan, Sandra L. Starnes, Joe B. Putnam, Hiran C. Fernando
Izdano 2016Artigo -
11
Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: Results from the ACOSOG Z4032 (Alliance) multicenter randomized trial od Hiran C. Fernando, Rodney J. Landreneau, Sumithra J. Mandrekar, Francis C. Nichols, Thomas A. DiPetrillo, Bryan F. Meyers, Dwight E. Heron, Shauna L. Hillman, David R. Jones, Sandra L. Starnes, Angelina D. Tan, Benedict D.T. Daly, Joe B. Putnam
Izdano 2014Artigo -
12
Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non–small cell lung cancer: Results from a multicenter phase III study od Hiran C. Fernando, Rodney J. Landreneau, Sumithra J. Mandrekar, Shauna L. Hillman, Francis C. Nichols, Bryan F. Meyers, Thomas A. DiPetrillo, Dwight E. Heron, David R. Jones, Benedict D.T. Daly, Sandra L. Starnes, Angelina D. Tan, Joe B. Putnam
Izdano 2011Artigo -
13
Impact of Brachytherapy on Local Recurrence Rates After Sublobar Resection: Results From ACOSOG Z4032 (Alliance), a Phase III Randomized Trial for High-Risk Operable Non–Small-Cell... od Hiran C. Fernando, Rodney J. Landreneau, Sumithra J. Mandrekar, Francis C. Nichols, Shauna L. Hillman, Dwight E. Heron, Bryan F. Meyers, Thomas A. DiPetrillo, David R. Jones, Sandra L. Starnes, Angelina D. Tan, Benedict D.T. Daly, Joe B. Putnam
Izdano 2014Artigo -
14
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question—Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head od Ross A. Abrams, Kathryn Winter, Howard Safran, Karyn A. Goodman, William F. Regine, Adam C. Berger, Michael T. Gillin, Philip A. Philip, Andrew M. Lowy, Abraham J. Wu, Thomas A. DiPetrillo, Benjamin W. Corn, Samantha A. Seaward, Michael G. Haddock, Suisui Song, Yixing Jiang, Barbara J. Fisher, Alan W. Katz, Sharmila Mehta, Christopher G. Willett, Christopher H. Crane
Izdano 2020Artigo -
15
TRAIL agonists rescue mice from radiation-induced lung, skin or esophageal injury od Jillian Strandberg, Anna D. Louie, Seulki Lee, Marina Hahn, Praveen Srinivasan, Andrew George, Arielle De La Cruz, Leiqing Zhang, Liz Hernandez Borrero, Kelsey E. Huntington, Payton De La Cruz, Attila A. Seyhan, P.P. Koffer, David E. Wazer, Thomas A. DiPetrillo, Stephanie L. Graff, Christopher G. Azzoli, Sharon Rounds, Andres J. Klein–Szanto, Fabio Tavora, Evgeny Yakirevich, Abbas E. Abbas, Lanlan Zhou, Wafik S. El‐Deiry
Izdano 2025Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Surgery
Oncology
Radiation therapy
Lung cancer
Brachytherapy
Cancer
Radiology
Biology
Chemotherapy
Confidence interval
Hazard ratio
Lung
Randomized controlled trial
Resection
Adverse effect
Biochemistry
Cell biology
Chemistry
Chemoradiotherapy
Clinical endpoint
Disease
Epidermal growth factor receptor
Erlotinib
Gastroenterology
Nuclear medicine
Resection margin
Toxicity
Ablation